VAERS 1736739
PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge N6198
- Staat
- TX
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 27.09.2021
- Impfdatum
- 27.02.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 194,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Symptomtext
Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/6/2021 and 2/27/2021. Patient stated he received a third COVID vaccine around the 1st of September 2021 but unable to verify with documentation. Patient presented to ED on 9/9/2021 for hypoxia. Hospitalized for COVID pneumonia. Dexamethasone, levofloxacin, zosyn, vancomycin, and remdesivir were administered. Patient continued to decompensate throughout hospitalization. Patient was transitioned to comfort care on 9/20/2021 and expired at 1734 on 9/20/2021.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- 11,0
- Labordaten
- COVID Positive on 9/6/2021; Chest X-ray revealed Marked bilateral lung consolidation with reactive lymphadenopathy on 9/9/2021
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Interstitial lung disease, acute renal failure, antisynthetase syndrome, myositis, pulmonary fibrosis
- Andere Medikamente
- Prednisone 40 mg daily, mycophenolate 500 mg three times daily
- Allergien
- Penicillin
- Vorherige Impfungen
- -